|
POLR2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.323300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.859610E-03 |
| Normal-vs-Stage2 |
6.155800E-01 |
| Normal-vs-Stage3 |
4.679600E-02 |
| Normal-vs-Stage4 |
3.094100E-02 |
| Stage1-vs-Stage2 |
2.531600E-01 |
| Stage1-vs-Stage3 |
9.443800E-01 |
| Stage1-vs-Stage4 |
9.492400E-01 |
| Stage2-vs-Stage3 |
3.085800E-01 |
| Stage2-vs-Stage4 |
3.843600E-01 |
| Stage3-vs-Stage4 |
9.859800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.160700E-03 |
| Normal-vs-AfricanAmerican |
3.279700E-02 |
| Normal-vs-Asian |
5.232000E-01 |
| Caucasian-vs-AfricanAmerican |
8.572200E-01 |
| Caucasian-vs-Asian |
9.894200E-01 |
| AfricanAmerican-vs-Asian |
9.597000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.615660E-04 |
| Normal-vs-Female |
9.201600E-01 |
| Male-vs-Female |
5.296200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.077700E-03 |
| Normal-vs-Extreme_Weight |
4.026400E-04 |
| Normal-vs-Obese |
7.573500E-02 |
| Normal-vs-Extreme_Obese |
1.128440E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.950800E-01 |
| Normal_Weight-vs-Obese |
2.928600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.434400E-01 |
| Extreme_Weight-vs-Obese |
1.088620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.781600E-01 |
| Obese-vs-Extreme_Obese |
4.062000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.584400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.222200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.394000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.038040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.131600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.569700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.311700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.401400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.015380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.388800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.656100E-03 |
| Normal-VS-Type2 PRCC |
3.184300E-04 |
| Normal-VS-KIRP CIMP |
2.947600E-01 |
| Normal-VS-Unclassified PRCC |
4.896000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.143180E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.444400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.698600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.282800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.173700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.196000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.73649999999959E-05 |
| Normal-vs-N1 |
2.999800E-01 |
| Normal-vs-N2 |
6.431700E-02 |
| N0-vs-N1 |
9.943700E-02 |
| N0-vs-N2 |
8.559400E-01 |
| N1-vs-N2 |
5.944400E-01 |
|
|
